Skip to main content

Bank of New York Mellon Corp

Bank

Position in VKTX — Viking Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in VKTX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$14,775,205
-$1,921,956 QoQ
Shares Held
454,063
-4.3% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 86.12967804027194.ToString("F0")% Shared 0.ToString("F0")% None 13.870321959728054.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. VKTX ranks #44 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,775,205 454,063
2025-12-31 $16,697,161 474,621
2025-09-30 $13,134,369 499,786
2025-06-30 $11,730,886 442,675
2025-03-31 $12,516,892 518,298
2024-12-31 $18,629,666 462,964
2024-09-30 $26,689,211 421,564
2024-06-30 $21,588,637 407,256
2024-03-31 $28,576,426 348,493
2023-12-31 $6,284,743 337,708
2023-09-30 $3,651,406 329,847
2023-06-30 $5,481,199 338,137
2023-03-31 $2,360,451 141,769
2022-12-31 $1,487,887 158,286
2022-09-30 $283,271 104,144
2022-06-30 $305,714 105,784
2022-03-31 $977,244 325,748
2021-12-31 $1,186,399 257,913
2021-09-30 $1,672,689 266,352
2021-06-30 $1,498,464 250,161
2021-03-31 $1,892,951 299,281
2020-09-30 $1,816,049 312,036
2020-06-30 $2,268,856 314,682
2020-03-31 $1,474,984 315,168